In addition, we constructed APC, p53, Kras mutants to explore key players driving the IFNγ/IFNGR2 axis given that they are common genetic mutations in colorectal cancers influencing CSC dynamics during tumor initiation [6]. The gene discussed is KRAS; the disease is colorectal cancer.